Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001263165-03-000003
Filing Date
2003-09-11
Accepted
2003-09-11 11:14:22
Documents
2
Period of Report
2003-09-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 4404
3 EDGAR SUPPORTING DOCUMENT poabenchimol.txt EX-24 2472
  Complete submission text file 0001263165-03-000003.txt   8715
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Issuer) CIK: 0001073431 (see all company filings)

EIN.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 1600 FARADAY AVENUE CARLSBAD CA 92008 7606037243
BENCHIMOL CLAUDE (Reporting) CIK: 0001263165 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-25317 | Film No.: 03891187